We are live on ! Find out more
DSCI

Derma Sciences, Inc. Common Stock (DE)
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

Back to rankings

1 hedge funds and large institutions have $1.61M invested in Derma Sciences, Inc. Common Stock (DE) in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 47

98% less funds holding

Funds holding: 52 → 1 (-51)

98% less capital invested

Capital invested by funds: $87.2M → $1.61M (-$85.6M)

Holders
1
Holders Change
-51
Holders Change %
-98.08%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
47
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
+$1.54M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$19.5M
2
Franklin Resources
Franklin Resources
California
-$13.9M
3
BC
Broadfin Capital
New York
-$13.3M
4
Jennison Associates
Jennison Associates
New York
-$7.34M
5
GIM
Granahan Investment Management
Massachusetts
-$5.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
FPF
1
FNY Partners Fund
New York
$1.61M +$1.54M +229,909 New
BBA
2
Baker Bros. Advisors
New York
– -$19.5M -3,752,390 Closed
Franklin Resources
3
Franklin Resources
California
– -$13.9M -2,667,600 Closed
BC
4
Broadfin Capital
New York
– -$13.3M -2,562,104 Closed
Jennison Associates
5
Jennison Associates
New York
– -$7.34M -1,412,577 Closed
GIM
6
Granahan Investment Management
Massachusetts
– -$5.97M -1,148,970 Closed
KAM
7
Krensavage Asset Management
New York
– -$4.63M -891,026 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$4.38M -843,287 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
– -$3.27M -629,600 Closed
Manulife (Manufacturers Life Insurance)
10
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$3.25M -624,154 Closed
RA
11
Royce & Associates
New York
– -$2.86M -549,341 Closed
DCM
12
DAFNA Capital Management
California
– -$1.84M -353,718 Closed
UBS AM
13
UBS AM
Illinois
– -$1.18M -227,704 Closed
Geode Capital Management
14
Geode Capital Management
Massachusetts
– -$663K -127,650 Closed
Connor, Clark & Lunn Investment Management (CC&L)
15
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$391K -75,200 Closed
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
– -$380K -72,997 Closed
OAM
17
Oberweis Asset Management
Illinois
– -$364K -70,000 Closed
Northern Trust
18
Northern Trust
Illinois
– -$326K -62,601 Closed
California Public Employees Retirement System
19
California Public Employees Retirement System
California
– -$294K -56,500 Closed
Goldman Sachs
20
Goldman Sachs
New York
– -$282K -54,236 Closed
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
– -$259K -49,791 Closed
CB
22
Commerce Bank
Missouri
– -$255K -48,958 Closed
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
– -$204K -39,267 Closed
CIS
24
Connors Investor Services
Pennsylvania
– -$118K -22,625 Closed
TC
25
TFS Capital
Pennsylvania
– -$99K -19,010 Closed
1
2

DSCI Hedge Fund Activity: Q1 2017 in Review

1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q1 2017, worth a combined $1.61M — down 98% from $87.2M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of DSCI and 1 opened new positions — a net loss of 46 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was FNY Partners Fund, opening a new position worth an estimated $1.54M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $19.5M sold.

  • 1 institutional investor held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q1 2017, down from 52 in Q4 2016.
  • Funds reported $1.61M of Derma Sciences, Inc. Common Stock (DE) stock for Q1 2017, down 98% quarter-over-quarter.
  • 1 fund opened new Derma Sciences, Inc. Common Stock (DE) positions in Q1 2017 and 47 closed out, a net change of -46 holders.
  • The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q1 2017 was FNY Partners Fund, an estimated $1.54M added.
  • The largest Derma Sciences, Inc. Common Stock (DE) seller in Q1 2017 was Baker Bros. Advisors, an estimated $19.5M sold.

Based on aggregated 13F filings for Q1 2017.